Xiong Li
Corporate Officer/Principal chez Hutchison MediPharma Ltd.
Profil
Xiong Li is currently the Vice President and Head of Inflammation & Immunology at Hutchison MediPharma Ltd.
Prior to this, Dr. Li worked as a Principal at Pfizer Pharmaceuticals Ltd.
and Glaxosmithkline China Ltd.
Dr. Li received a graduate degree from Shanghai Jiao Tong University, an undergraduate degree from Nankai University, and a doctorate degree from The University of North Carolina at Charlotte.
Postes actifs de Xiong Li
| Sociétés | Poste | Début |
|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | - |
Anciens postes connus de Xiong Li
| Sociétés | Poste | Fin |
|---|---|---|
Pfizer Pharmaceuticals Ltd.
 Pfizer Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Huizhi Pharmaceutical (Dalian) Co., Ltd. is a pharmaceutical manufacturing company in China. It is a subsidiary compnay of Pfizer, Inc. The company was founded in 1980 and is headquartered in Beijing, CN. | Corporate Officer/Principal | - |
| Glaxosmithkline China Ltd. | Corporate Officer/Principal | - |
Formation de Xiong Li
| Nankai University | Undergraduate Degree |
| Shanghai Jiao Tong University | Graduate Degree |
| The University of North Carolina at Charlotte | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Glaxosmithkline China Ltd. | |
Pfizer Pharmaceuticals Ltd.
Pfizer Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Huizhi Pharmaceutical (Dalian) Co., Ltd. is a pharmaceutical manufacturing company in China. It is a subsidiary compnay of Pfizer, Inc. The company was founded in 1980 and is headquartered in Beijing, CN. | Health Technology |